Superovulation: Mechanisms, Induction & Clinical Implications
Superovulation = development of multiple dominant follicles in a single cycle (>1 mature oocyte).
Physiology
- Normal: Monofollicular selection via FSH threshold, inhibin B, estradiol negative feedback
- Superovulation: FSH sustained above threshold → multiple follicles escape atresia
Induction Protocols
| Agent | Mechanism | Typical Use |
| Clomiphene citrate | ER antagonist → ↑ GnRH → ↑ FSH/LH | First-line ovulation induction (PCOS, unexplained) |
| Letrozole | Aromatase inhibitor → ↓ E2 → ↑ FSH | Preferred for PCOS (higher live birth, lower multiples) |
| Gonadotropins (rFSH, hMG) | Direct FSH/LH supplementation | IVF, IUI, clomiphene-resistant |
Risk Factors for Spontaneous Superovulation
- PCOS (high AMH, inherent FSH sensitivity)
- Age >35 (rising FSH, diminished feedback)
- Obesity (insulin → ovarian androgen → follicular recruitment)
- Genetic variants (FSHR, AMH, BMP15)
- Prior ovarian surgery (reduced inhibin)
Clinical Consequences
- Multiple Gestation: Twins 5–30% (clomiphene), 15–30% (gonadotropins); triplets+ rare but serious
- OHSS: Ovarian Hyperstimulation Syndrome (gonadotropins > oral agents)
- Prematurity, LBW, preeclampsia from multiples
Monitoring & Mitigation
- Serial ultrasound + estradiol
- Cycle cancellation if >3 follicles >16mm (IUI) or Coasting/agonist trigger (IVF)
- Elective single embryo transfer (eSET) in IVF
Superovulation is a tool, not a diagnosis. Individualized protocols balance efficacy and safety.
Infertility - Related Articles